Wagner da Nova Mussel
Associate Professor, Brazil
Dr. Wagner da Nova Mussel works as Associate Professor at the University of Minas Gerais - UFMG, Minas Gerais state in Brazil, has completed his Ph.D. at the age of 28 years from the same university and Trinity College of Dublin, postdoctoral studies in polymorphism. He has 30 years of experience in the field of applied X-ray diffraction in the university and collaborations with industry. Have more than 100 publications among papers in reputed journals and expanded abstracts in congresses, been serving as a reviewer in several specialized journals. Have conducted applied research in the thermal behavior of active pharmaceutical ingredients aim to contribute with the necessary knowledge of polymorphic speciation and characterization, implying in better efficiency and safety of use.
He has experience in the field of Chemistry with emphasis in Trace Analysis and Environmental Chemistry, working mainly in characterization, quantification and refinement of crystalline structure by X-ray diffraction, kinetic physicochemistry, Ferruginous minerals applied to catalysis and Mössbauer spectroscopy, characterization and polymorphic drug interactions.
Dr. Guertin has 30 years of experience in spinal cord research and 18 years of experience in science leadership. He was President and CEO of NeuroSpina Therapeutics between 2005 and 2008 as well as Chief Scientific Officer of Eurymedon HealthCare during the same period. During 8 years, he acted as President and CEO of Nordic Life Science Pipeline Inc. He is currently developing next-generation pharmaceutical, healthcare and skincare products for people with CNS trauma, paralysis and mobility impairment due to aging or disease. Over the years, he has obtained 5.5 million dollars in financing from not-for-profit public agencies and private foundations to conduct animal research (rodents), drug development and clinical studies. He has developed a cutting-edge expertise in spinal cord injury and aging, metabolic problems, urogenital and bowel problems, and musculoskeletal/dermatological degradation. He holds positions as Full Professor in the Department of Psychiatry & Neurosciences (Université Laval, 2001 - present) as well as Director and Principal Investigator of the Spinal Cord Injury and Functional Recovery Laboratory (2002 – present, Laval University Medical Center, Quebec). As a leading scientist, he is author and co-author of more than 175 publications (articles, reviews, book chapters, patents, etc.) since 1990. He acts also as editorial board member (32 international journals), referee and reviewer for granting agencies such as CIHR, NSERC, and FRSQ. Among several breakthrough findings made in his laboratory, his main accomplishment remains undoubtedly the discovery in 2004 and the development from bench-to-bedside of the first oral drug ever, SpinalonTM, capable of reactivating spinal locomotor neurons and eliciting basic walking activity in paralyzed animals and patients.
Professor & Chairman, Japan
Biography: Naoyuki Matsuda is the Professor & Chairman for Division of Emergency and Critical Care Medicine; Division of Biomedical Regulation and also for the Department of Emergency and Critical Care at Nagoya University.
Research Interest: Northern Blot; Reporter Assay; Regulation of Gene Expression; Septic Shock; siRNA; Temperature Gradient Gel Electrophoresis; Emergency Medicine; Emergency Management; Emergency Oncology; Emergency Surgery; Critical Care; Pharmacology; Infection Control; PCR; Endothelial Cells; Cell Culture; Cloning; SDS-PAGE; RNA Interference; Immunoprecipitation; Gene Regulation
Yavuz Selim Silay
Co-Founder & CEO MAIN, Greater New York City Area
Dr. Yavuz Selim Silay is the Co-Founder & CEO of MAIN(MaQasid Angel Investors Network) & chairman of Istanbul Consulting Group. MAIN(MaQasid Angel Investor Network) is one the fast growing global angel investment groups . ICG(Istanbul Consulting Group) which was founded in 2013 and provided guidance to the Turkish ministry of health as part of a World Bank project.Yavuz is currently the Co-Founder of BioCube ?stanbul Bioentrepreneurship & Innovation Center and Corporate Communication Director of Archem Diagnostics. He previously managed the largest distributor of Siemens Healthcare in Turkey managing 250 employees and director of Avc?lar Hospital R&D Center, Chief Medical Officer of Lifematrix GmbH. Previously he worked as the Market Access & Health Policy Director for AIFD in Turkey.
: Interaction with FDA. Development of generic and branded regulatory strategic plans for new product development, life cycle management of marketed products. Evaluation of potential products & in-licensing opportunities. Participate in all aspects of clinical development & study management, providing scientific, medical, and logistical direction and support to studies.Clinical development in CNS/Pain Managing Phase 2-4 clinical trials
, Principal of Moulana College of Pharmacy, Angadippuram P.O., Perinthalmanna, received her Ph. D Degree in “Pharmaceutical Sciences” from The Tamil Nadu Dr. M.G.R Medical University at Chennai, Tamil Nadu state. She is also HOD of Department of Pharmacognosy. She is having 24 years of experience in the field of teaching and guiding several PG projects related with Pharmacognstic, Phytochemical, Formulation development and standardization by Analytical methods. Her area of Expertise includes:- Herbal Standardization, qualitative & quantitative analysis of drugs using instrumental methods, Phytochemical studies, isolation and characterization of compounds.
She has received the three best paper awards in the international and national conferences. She has guided more than 25 PG projects which has obtained scholarships from the Tamil Nadu Welfare Fund Association, Government of India and Department of Ayurveda - NSTMIS
is a Prof in the Department of Basic Sciences, Faculty of Dental Medicine/Damascus University. He is a specialist in analytical and industrial chemistry. He obtained many awards and published more than 50 peer-reviewed papers (two of them in French) in Environmental Sciences, Green Chemistry, Analytical Chemistry, Synthesis Chemistry, Concrete, Ceramics, Paper Industry, Petrochemical, Extraction, Separation, Lithium-Ion-Batteries, and Oral Chemistry. He is a partner in Advances in Cleaner Production Network, and a member of the German Chemical Society e.V. (GDCh), Asian Chemical Society, and the American University of Beirut. He is a member of the higher committee of the 6th International Workshop-Advance in Cleaner Production (São Paulo, Brazil (May 24th to 26th - 2017)) and in more than 20 conference organizing committees. Loai Aljerf is in the Cambridge Scholars Publishing-Life Science Advisory Board and an editor of more than 50 journals and a reviewer for Top journals in Industry, Chemical Engineering, and Environmental Chemistry.
Industrial Chemistry, Analytical Chemistry, Environmental Chemical Engineering, Environmental Science, Environmental Chemistry, Green Chemistry, Cement Industry, Ceramics, Paper Industry, Advances in Cleaner Production, Climate Change, Pollution, Wastewater Treatment, Air Pollution, Eco-friendly Biopolymers, Polycyclic Aromatic HydrocarbonsAdsorption, Ecology and Natural Resources, Biodiversity, Sustainable Development, Waste Management, Environmental Management, Life Cycle Assessment, Ecodesign, Design for the Environment, Energy Labeling, Eco-efficiency, Chromatography, HPLC, GC, MS, AAS, Spectroscopy, and Lithium-Ion-Batteries.
Ramesh C. Gupta
Pro Vice Chancellor Nagaland Central University, India
Dr. Ramesh Gupta is Dean SASRD, & Professor of chemistry at Nagaland University India. He received his Bachelor of Science in Biochemical Science, and Master of Science in organic chemistry from Lucknow University India, and Doctorate in Chemistry at Lucknow University, on Drug Development. Dr. Ramesh Gupta is a Medicinal & Bioorganic Chemist and has worked for several years as visiting professor/Scientist in various Medical schools; Louis pasture University France, University of Arizona USA, Osaka University & Nagoya University Japan, Kyung Hee University, Korea advance institute of science and technology (KAIST) Korea, Ben-Gurion University Israel, Linkoping University Sweden, University of Mons Belgium, University of Western Australia, Sydney ,University of Bergen ,Norway and some others. Prof Guptas’ research focuses on the Natural & Synthetic Drug Development, role of sulfur amino acids in health care, functional food, nutraceuticals and environmental Biotechnology & gender issues.